Silver Book

Silver Book Fact

It is estimated that those aged 50 years or older with macular degeneration will double– 9 million to 18 million– by 2050.

Saaddine, Jinana B., Amanda A. Honeycutt, K.M. Venkat Narayan, Xinzhi Zhang, Ron Klein, and James P. Boyle. Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People with Diabetes Mellitus: United States 2005-2050. Arch Ophthalmol. 2008; 126(12): 170-7. http://archopht.ama-assn.org/cgi/reprint/126/12/1740.pdf

Reference

Title
Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People with Diabetes Mellitus: United States 2005-2050
Publication
Arch Ophthalmol
Publication Date
2008
Authors
Saaddine, Jinana B., Amanda A. Honeycutt, K.M. Venkat Narayan, Xinzhi Zhang, Ron Klein, and James P. Boyle
Volume & Issue
Volume 126, Issue 12
Pages
170-7
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • Surgical procedure to relieve pressure in the eyes of glaucoma patients
    A common surgical procedure to relieve pressure in the eyes of glaucoma patients where other treatments have not been effective, was found to increase the risk of cataract formation by…  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with age-related macular degeneration (AMD) is $575 million.  
  • Losing eyesight potential for greatest impact on day-to-day life poll finds
    Poll finds losing eyesight as potentially having greatest impact on day-to-day life–more than other conditions including loss of limb, memory, hearing, and speech (57% of African Americans polled, 49% of non-Hispanic…  
  • Over a 1-year period, 54% of individuals with age-related macular degeneration (AMD) reported a fall and 30% reported more than one.  Of all reported falls, 63% resulted in an injury.  
  • Age-Related eye diseases affect more than 35 million Americans age 40 and older. The most common eye diseases in that age group are macular degeneration, glaucoma, diabetic retinopathy, and cataract.